US Patent Issued to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), Assistance Publique-Hopitaux de Paris (APHP), Universite de Paris, Fondation Imagine, Universite Paris-Sud on Dec. 9 for "EGFR inhibitors for treating keratodermas" (French Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,186, issued on Dec. 9, was assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris), Assistance Publique-Hopitaux de Paris (APHP) (Paris), Universite de Paris (Paris), Fondation Imagine (Paris) and Universite Paris-Sud (Orsay, France).

"EGFR inhibitors for treating keratodermas" was invented by Christine Bodemer (Paris), Celine Greco (Villejuif, France) and Claude Boucheix (Villejuif, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "Olmsted syndrome (OS) is a rare genodermatosis classically characterized by the combination of bilateral mutilating transgredient palmoplantar keratoderma (PPK) and periorificial keratot...